Concepedia

Aaron Lisberg

AL

45

Publications

9.3K

Citations

25

H-Index

2002

Active since

Affiliations

University of California, Los Angeles(Current)

Daiichi Sankyo (United States)

Dana-Farber Cancer Institute

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Aaron Lisberg is an author at University of California, Los Angeles specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2002–2025

45

Publications

45

RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow

Yuehua Jiang, Balkrishna Jahagirdar, R. Lee Reinhardt et al. · Nature · 2002 · 5.5K citations

, , +12

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan et al. · The Lancet Oncology · 2017 · 1.1K citations · Full text

, , +9

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman et al. · Journal of Thoracic Oncology · 2018 · 577 citations · Full text

, , +7

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Katherine Hastings, Helena A. Yu, Wen Wei et al. · Annals of Oncology · 2019 · 352 citations · Full text

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study

Kelly G. Paulson, Christopher W. Lewis, Mary W. Redman et al. · Cancer · 2016 · 175 citations · Full text

Rows per page

1–5 of 45